Boston Patent Law Association Annual Meeting

Slides:

Advertisements

Similar presentations

1 TC1600-Quality Assurance Bennett Celsa QAS Joseph Woitach SPE June 4, 2013.

Advertisements

Bicoastal Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting RCE Progress Update Daniel Sullivan Director, TC1600 September 17, 2014.

1 © 2014 Knobbe, Martens, Olson & Bear, LLP all rights reserved. Advantages and Disadvantages of PPH Mark Abumeri 9 November 2014 Asian Patent Attorneys.

1 1 1 AIPLA American Intellectual Property Law Association USPTO Updates Including Glossary Pilot Program Chris Fildes Fildes & Outland, P.C. IP Practice.

1 1 AIPLA American Intellectual Property Law Association RCE Practice: Pilot Programs and Delays in Examination Chris Fildes Fildes & Outland, P.C. IP.

Q. TODD DICKINSON EXECUTIVE DIRECTOR, AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) USPTO PUBLIC MEETING JULY 20, 2010 AIPLA Comments: Enhanced.

July 8, Enhanced Examination Timing Control Robert A. Clarke Deputy Director Office of Patent Legal Administration

United States Patent and Trademark Office – 1 Patent Prosecution Highway (PPH) United States Patent and Trademark Office.

John J. Calvert Administrator, Inventor Assistance Program John J. Calvert Administrator, Inventor Assistance Program Patents – Past, Present and Future.

Application Filings and Examiner Production. UPR Applications Filed

THE STATE OF THE PATENT SYSTEM BACKGROUND FOR RULE PROPOSALS Los Angeles Intellectual Property Law Association “Washington and the West” Conference January.

Safekeeping of 35 U.S.C. 156 Extensions

Patent Term Adjustment (Bio/Chem. Partnership) Kery Fries, Sr. Legal Advisor Phone: (571)

Boston Patent Law Association Joseph Rolla – Deputy Commissioner for Patent Examination Policy.

Patent Quality Assurance Program. 2 Office of Patent Quality Assurance (OPQA) Deputy Commissioner for Patent Operations Office of Patent Quality Assurance.

Prosecution Luncheon Patent July Calendar AIPLA –PCT Seminar  July San Francisco  July Alexandria IPO Annual Meeting –Sept

1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Anthony Caputa, Ph.D. Technology Center Practice Specialist TC 1600.

A View from Both Worlds: USPTO and the Federal Labs Mojdeh Bahar, J.D.,M.A. Technology Licensing Specialist Office of Technology Transfer National Institutes.

Remy Yucel Director, CRU (571) Central Reexamination Unit and the AIA.

Customer Partnership Meeting John Doll Commissioner for Patents.

1 AIPLA Biotech Committee Meeting Washington D.C., October 14, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)

11 IP Section Colorado Bar Association Robert Stoll Commissioner for Patents United States Patent and Trademark Office.

1 Patent Quality Initiatives Biotechnology/Chemical/Pharmaceutical Customer Partnership Tuesday, April 7, 2015 Valencia Martin-Wallace Deputy Commissioner.

1 Biotechnology/Chemical/Pharmaceutical Customer Partnership June 1, 2010 Valencia Martin-Wallace – Director, Technology Center 2400.

1 Business Method Patents The USPTO Perspective Prepared for the Casualty Actuary Society Annual Meeting November 15, by John J. Love The United.

MISSOURI COMPREHENSIVE DATA SYSTEM OFFICE OF DATA SYSTEM MANAGEMENT Missouri Department of Elementary and Secondary Education July 26, 2011.

USPTO Public Meeting July 20, 2010 Enhanced Examination Timing Control Initiative Hans Sauer, Biotechnology Industry Organization.

MD Digital Government Summit, June 26, Maryland Project Management Oversight & System Development Life Cycle (SDLC) Robert Krauss MD Digital Government.

USPTO Patent Quality Composite presented to Biotechnology/Chemical/Pharmaceutical Customer Partnership September 5, 2012 by Martin Rater Statistician USPTO,

Biotech Customer Partnership August 3, 2004 Jasemine C. Chambers, Ph.D., J.D. Director Technology Center 1600 USPTO (571)

Prosecution Luncheon Patent August Calendar IPO Annual Meeting –Sept Chicago Indy Bar –At the Bar with the Bench Tonight, Aug. 20 th 5:30.

Christian Chace Patent Process Reengineering Team December 8, 2010 Patent Process Reengineering Team and Patent End-To-End Processing Team The Biotechnology.

After Final Practice Linda M. Saltiel June 2, 2015.

NCAR’s Societal Impacts Program: WIST-Related Research Efforts Julie Demuth NCAR Societal Impacts Program 3 rd National Surface Transportation Weather.

1 IP Infrastructure for Promotion of Work Sharing - Japan’s Perspective - Koichi MINAMI Deputy Commissioner Japan Patent Office WIPO Global Symposium of.

Compact Prosecution Bennett Celsa TC Quality Assurance Specialist (December 2009)

USPTO Updated Strategic Plan in Brief March 3 rd, 2010.

Christian Chace Patent Process Reengineering Team September 8, 2010 Patent Process Reengineering Team as part of the Patent End-To-End Processing Team.

111 Teresa Stanek Rea Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office.

QualityDefinition.PPACMeeting AdlerDraft 1 1 Improving the Quality of Patents Marc Adler PPAC meeting June 18, 2009.

Pilot Concerning Public Submission of Peer Reviewed Prior Art Jack Harvey Director, TC 2100.

Chris Fildes FILDES & OUTLAND, P.C. IP Practice in Japan Committee Pre-Meeting AIPLA Annual Meeting, October 20, 2015 USPTO PILOT PROGRAMS 1 © AIPLA 2015.

Copyright © 2015 Oblon, McClelland, Maier & Neustadt, LLP Inside the USPTO Peggy Focarino Senior Patent Advisor.

1 Biotech/Chem/Pharm Customer Partnership Meeting June 15, 2005 USPTO Study on Restriction Reform and Update on TC1600 Restriction Practice Action Plan.

Prosecution Group Luncheon May, Obviousness—In re Kao (FC 2011) BPAI affirms obviousness rejection: using reference formula, POSA can replace reference’s.

FY 2010 and FY 2011 USPTO Financial Report Trademark Public Advisory Committee Meeting February 25, 2010.

Prosecution Lunch October Bits and Pieces from the Patent Side Crowing about reduction in pending cases –From 750K a year ago to about 708K now.

First Action Interview Pilot Program Legal Secretaries & Administrators Conference June 18, 2009.

1. Video Conference Interviews 2 Sean Hagan Director of the Midwest Regional United States Patent and Trademark Office Webinar for Knobbe Martens January.

The United States Patent and Trademark Office January 27, 2005.

1 FY08 Restriction Petition Update and Burden Julie Burke Quality Assurance Specialist Technology Center 1600.

1 The Patent Prosecution Highway A Brief History and Current Status Mark R. Powell Director, TC 2600 USPTO.

2 Jesus J. Hernandez Patent Attorney Office of Policy and International Affairs The INPI-USPTO Patent Prosecution Highway Pilot Program Seminario Sobre.

USPTO Biotechnology, Chemical, and Pharmaceutical Customer Partnership Meeting June 30, 2016 Stakeholder’s Perspective on Patent Quality Initiative Frank.

EE Third-Party Solicitation Process Workshop Solicitation Alignment

Demand Management Overview Title Slide

Draft Strategy To Optimize Resource Management of Storm Water

Examination Time and the Production System

American Intellectual Property Lawyers Association 2015 Spring Meeting Los Angeles, California April 29 – May 2, 2015 John Cabeca Director of the.

Overview of the FEPAC Accreditation Process

Professional & Scientific Council Update

Protection of Intellectual Property Resulting from STCU Projects

ONRR Compliance Process Improvement

Milena Lonati PD Quality Management DG2, European Patent Office

Evaluation in the GEF and Training Module on Terminal Evaluations

First Action Interview Pilot Program

SmartMeterTM Steering Committee Update – July 2012

Los Angeles Intellectual Property Law Association

The National Association of Patent Practitioners (NAPP)

The Role of Data and Analytics in the Healthcare Ecosystem

Presentation transcript:

Boston Patent Law Association Annual Meeting Drew Hirshfeld Commissioner for Patents, USPTO December 7, 2017

Patents Workforce (as of Oct. 2017) 9,970 total employees 8,152 total Patent Examiners Of which 186 are Design Examiners

Priorities

Priorities: Pendency Quality Metrics Clarity & Correctness Data Capture (Master Review Form, or MRF) Appeal Statistics Interview Practice Examination Time Analysis Expanded Collaborative Search Pilot (CSP) Access to Relevant Prior Art Stakeholder Outreach

Pendency Pendency First Action Pendency Total Pendency Patent Term Adjustment (PTA) Timeframes Compliance

FY17 Targets, Results and FY18 Targets Patent Pendency FY17 Targets FY17 Results FY18 Targets First Action Pendency 15.5 16.3 15.4 Total Pendency 25.5 24.2 25 Patent Term Adjustment (PTA) Timeframes 14/4/4/4/36 14 months to First Action N/A 44% 47%

Pendency Pendency First Action Pendency Total Pendency Patent Term Adjustment (PTA) Timeframes Compliance

Quality Metrics Quality Metrics Product indicators, process indicators, and perception indicators Product indicators – correctness (“statutory compliance”) and clarity Quality Metrics

Clarity & Correctness Data Capture (Master Review Form, or MRF) Consistently capturing minable data about the correctness and clarity of examiner work Over 50% more reviews per year 8,000 per year FY15 and prior Minimum 12,000 anticipated in FY18 Clarity & Correctness Data Capture (Master Review Form, or MRF)

Quality Metrics and MRF FY15 and Prior FY18 Total # of Reviews 8,000 per year Minimum 12,000 Potential Data Points per Review 240 330 Scope of Review Overall Office action compliance Assessing whether there was a deficiency that would adversely impact advancement of prosecution, e.g., 2+ non-final, re-opening prosecution, etc. Statutory compliance Assessing whether examiner made (or should have made) a prima facie case in rejecting any claim under any statute Reporting Granularity Individual Technology Centers Individual Workgroups within each Technology Center

Clarity & Correctness Data Capture (Master Review Form, or MRF) Consistently capturing minable data about the correctness and clarity of examiner work Over 50% more reviews per year 8,000 per year FY15 and prior Minimum 12,000 anticipated in FY18 Clarity & Correctness Data Capture (Master Review Form, or MRF)

Appeal Statistics − PTAB Results Overall affirmance rate of 56% for FY17 Additional 12% affirmed-in-part Tech center rates range from 43% (3700) to 68% (1600) Appeal Statistics

Interview Practice Interview Practice Advance Patent Prosecution Through Video Conferencing Simplify your interview request with the online USPTO Automated Interview Request (AIR) form. 12,264 USPTO AIR requests in 2016 Interview Practice

Examination Time Analysis Studying examination goals Ensuring optimal pendency and quality Suggested by oversight bodies Factors to be considered Examiner and stakeholder feedback Technology advancements Cooperative Patent Classification (CPC) Examination Time Analysis

Expanded Collaborative Search Pilot (CSP) Benefits: It’s free! Applications are fast tracked, and achieves stronger IP protection across multiple countries Combined search provides more comprehensive prior art Average allowances in 8-9 months Expanded Collaborative Search Pilot (CSP)

Access to Relevant Prior Art Provide examiners with info from related cases as early as possible Potentially reduces applicant’s burden to comply with duty of disclosure Completion of initial phase expected end of FY18 Access to Relevant Prior Art

Stakeholder Outreach Stakeholder Outreach Cybersecurity Partnership (Feb. 2017, Sep. 2017) Biotech Chemical Pharma Customer Partnership (Mar. 2017) Design Day (Apr. 2017) TC 1700 Additive Manufacturing Partnership (June 2017) TCs 3600 & 3700 Mechanical Partnership (June 2017) TC 2600 Partnership (July 2017) TC 1600 Partnership (Aug. 2017) TC 2800 Semiconductor Partnership (Aug. 2017) TC 3600 Business Methods Customer Partnership (Sep. 2017) Partnering in Patents (Oct. 2017) Stakeholder Outreach